Close
ACHEMA MIDDLE EAST 2026

AI Revolutionizes Drug Discovery And Development Process

The world is very interested in generative artificial intelligence (GAI), and for good reason. People have a better idea of what AI can do...

AI In Drug Development: Calls For Straightforward Regulation

A full-day training called Artificial Intelligence in Drug and Biological Product Development was held on August 6, 2024, by the Food and Drug Administration...

Scaling Cell And Gene Therapies: Challenges And Solutions

It is not always easy to go from novel research to a working business plan. There are still problems with prices and safety, as...

The Cell & Gene Therapy – From Innovation To Market Growth

In 2023, the market for cell and gene therapy was worth USD 18.8 billion. In the years to come, the market is projected to...

Advances And Challenges In The Gene Therapy Manufacturing

Cell and gene treatments are now one of the pharmaceutical industry’s fastest-growing segments, with more and more being investigated for a variety of purposes. The...

Impact of AI On Drug Development And Discovery Process

Since artificial intelligence (AI) has the exciting potential to transform every sector and change established processes, it is now the talk of the town....

Dosing Gets Further Precision With New Drug Delivery Tech

Throughout the last four to five years, there has been a persistent problem, which was noted by Willus Fisher, a doctoral candidate at UC...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...